BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 22966808)

  • 1. Health-related quality of life in Colombia: reference values of the EORTC QLQ-C30.
    Finck C; Barradas S; Singer S; Zenger M; Hinz A
    Eur J Cancer Care (Engl); 2012 Nov; 21(6):829-36. PubMed ID: 22966808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. European reference values for the quality of life questionnaire EORTC QLQ-C30: Results of a German investigation and a summarizing analysis of six European general population normative studies.
    Hinz A; Singer S; Brähler E
    Acta Oncol; 2014 Jul; 53(7):958-65. PubMed ID: 24456505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of change of quality of life in terminally ill patients under cancer pain management using the EORTC Core Quality of Life Questionnaire (QLQ-C30) in a Korean sample.
    Park KU
    Oncology; 2008; 74 Suppl 1():7-12. PubMed ID: 18758191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. General Spanish population normative data analysis for the EORTC QLQ-C30 by sex, age, and health condition.
    Arraras JI; Nolte S; Liegl G; Rose M; Manterola A; Illarramendi JJ; Zarandona U; Rico M; Teiejria L; Asin G; Hernandez I; Barrado M; Vera R; Efficace F; Giesinger JM;
    Health Qual Life Outcomes; 2021 Aug; 19(1):208. PubMed ID: 34461909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The EORTC Quality of Life Questionnaire for cancer patients (QLQ-C30): Australian general population reference values.
    Mercieca-Bebber R; Costa DS; Norman R; Janda M; Smith DP; Grimison P; Gamper EM; King MT
    Med J Aust; 2019 Jun; 210(11):499-506. PubMed ID: 31155722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. General population normative data for the EORTC QLQ-C30 health-related quality of life questionnaire based on 15,386 persons across 13 European countries, Canada and the Unites States.
    Nolte S; Liegl G; Petersen MA; Aaronson NK; Costantini A; Fayers PM; Groenvold M; Holzner B; Johnson CD; Kemmler G; Tomaszewski KA; Waldmann A; Young TE; Rose M;
    Eur J Cancer; 2019 Jan; 107():153-163. PubMed ID: 30576971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EORTC QLQ-C30 and FACT-Lym for the assessment of health-related quality of life of newly diagnosed lymphoma patients undergoing chemotherapy.
    Georgakopoulos A; Kontodimopoulos N; Chatziioannou S; Niakas D
    Eur J Oncol Nurs; 2013 Dec; 17(6):849-55. PubMed ID: 23850411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Normative data for the EORTC QLQ-C30 from the Austrian general population.
    Lehmann J; Giesinger JM; Nolte S; Sztankay M; Wintner LM; Liegl G; Rose M; Holzner B;
    Health Qual Life Outcomes; 2020 Aug; 18(1):275. PubMed ID: 32787854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality of life in patients with brain metastases using the EORTC QLQ-BN20+2 and QLQ-C15-PAL.
    Caissie A; Nguyen J; Chen E; Zhang L; Sahgal A; Clemons M; Kerba M; Arnalot PF; Danjoux C; Tsao M; Barnes E; Holden L; Danielson B; Chow E
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1238-45. PubMed ID: 22172909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age, sex, and comorbidities were considered in comparing reference data for health-related quality of life in the general and cancer populations.
    Yun YH; Kim SH; Lee KM; Park SM; Kim YM
    J Clin Epidemiol; 2007 Nov; 60(11):1164-75. PubMed ID: 17938059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reference values for the EORTC QLQ-C30 quality of life questionnaire in a random sample of the Swedish population.
    Derogar M; van der Schaaf M; Lagergren P
    Acta Oncol; 2012 Jan; 51(1):10-6. PubMed ID: 21961499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The EORTC QLQ-OH17: a supplementary module to the EORTC QLQ-C30 for assessment of oral health and quality of life in cancer patients.
    Hjermstad MJ; Bergenmar M; Fisher SE; Montel S; Nicolatou-Galitis O; Raber-Durlacher J; Singer S; Verdonck-de Leeuw I; Weis J; Yarom N; Herlofson BB
    Eur J Cancer; 2012 Sep; 48(14):2203-11. PubMed ID: 22572480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The European Organization for Research and Treatment of Cancer QLQ-C30: an examination into the cultural validity and reliability of the Turkish version of the EORTC QLQ-C30.
    Guzelant A; Goksel T; Ozkok S; Tasbakan S; Aysan T; Bottomley A
    Eur J Cancer Care (Engl); 2004 May; 13(2):135-44. PubMed ID: 15115469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minimal important differences in the EORTC QLQ-C30 in patients with advanced cancer.
    Bedard G; Zeng L; Zhang L; Lauzon N; Holden L; Tsao M; Danjoux C; Barnes E; Sahgal A; Poon M; Chow E
    Asia Pac J Clin Oncol; 2014 Jun; 10(2):109-17. PubMed ID: 23551530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EORTC QLQ-C30 general population normative data for Italy by sex, age and health condition: an analysis of 1,036 individuals.
    Pilz MJ; Gamper EM; Efficace F; Arraras JI; Nolte S; Liegl G; Rose M; Giesinger JM;
    BMC Public Health; 2022 May; 22(1):1040. PubMed ID: 35610611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health-related quality of life in early breast cancer.
    Groenvold M
    Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of quality of life of nasopharyngeal carcinoma patients with EORTC QLQ-C30 and H&N-35 modules.
    Cengiz M; Ozyar E; Esassolak M; Altun M; Akmansu M; Sen M; Uzel O; Yavuz A; Dalmaz G; Uzal C; Hiçsönmez A; Sarihan S; Kaplan B; Atasoy BM; Ulutin C; Abacioğlu U; Demiral AN; Hayran M
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1347-53. PubMed ID: 16169671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Symptom prevalence and management of cancer patients in Lebanon.
    Abu-Saad Huijer H; Abboud S; Doumit M
    J Pain Symptom Manage; 2012 Sep; 44(3):386-99. PubMed ID: 22727948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive factors of overall quality of life in advanced cancer patients using EORTC QLQ-C30.
    Cramarossa G; Zeng L; Zhang L; Tseng LM; Hou MF; Fairchild A; Vassiliou V; Jesus-Garcia R; Alm El-Din MA; Kumar A; Forges F; Chie WC; Sahgal A; Lam H; Pulenzas N; Chow E
    Expert Rev Pharmacoecon Outcomes Res; 2014 Feb; 14(1):139-46. PubMed ID: 24325545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding the reliability and validity of the EORTC QLQ-C30 in Turkish cancer patients.
    Cankurtaran ES; Ozalp E; Soygur H; Ozer S; Akbiyik DI; Bottomley A
    Eur J Cancer Care (Engl); 2008 Jan; 17(1):98-104. PubMed ID: 18181898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.